Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Update lptrimipramine.json #4276

Merged
merged 4 commits into from
Sep 18, 2023
Merged
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
38 changes: 26 additions & 12 deletions openprescribing/measure_definitions/lptrimipramine.json
Original file line number Diff line number Diff line change
@@ -1,17 +1,23 @@
{
"name": "NHS England Low Priority Treatment - trimipramine",
"title": [
"Trimipramine cost per 1000 patients"
],
"description": [
"Cost of trimipramine per 1000 patients"
],
"name": "Items which should not routinely be prescribed in primary care - trimipramine",
"title": "Trimipramine cost per 1000 patients",
"description": "Cost of trimipramine per 1000 patients",
"numerator_short": "Trimipramine cost (£)",
"denominator_short": "1000 patients",
"why_it_matters": [
"Trimipramine is an older tricyclic antidepressant. The cost has increased significantly recently, ",
"and there are newer, cheaper alternatives are available, which are ",
"<a href='https://www.nice.org.uk/Guidance/CG90'> recommended by NICE in preference to tricyclic antidepressants</a>. "
"<p><a href='https://www.england.nhs.uk/long-read/items-which-should-not-routinely-be-prescribed-in-primary-care-policy-guidance/#trimipramine-2017' target='_Blank'>",
"NHS England guidance states</a>:</p>",
"<i><p>The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.</p>",
"<p>NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if indicated as they have a more favourable risk-to-benefit ratio ",
"compared to TCAs. However, if a TCA is required, more cost-effective TCAs than trimipramine are available.</p>",
"<p>Due to the significant cost associated with trimipramine and the availability of alternative treatments, the joint clinical working group considered trimipramine suitable for inclusion in this guidance.</p></i>",
"<p>NHS England recommend that GPs:",
"<ul>",
"<li>Do not initiate.</li>",
"<li>Deprescribe in patients currently prescribed this medicine.</li>",
"<li>Prescribe only if no other item or intervention is clinically appropriate.</li>",
"<li>Prescribe only if no other item or intervention is available.</li>",
"</ul>"
],
"tags": [
"cost",
Expand All @@ -27,5 +33,13 @@
"numerator_bnf_codes_filter": [
"0403010Y0 # Trimipramine Maleate"
],
"denominator_type": "list_size"
}
"denominator_type": "list_size",
"authored_by": "[email protected]",
"checked_by": "[email protected]",
"date_reviewed": "2023-08-15",
"next_review": "2025-08-15",
"measure_complexity": "low",
"measure_type": "bnf_code",
"radar_exclude": false

}